Literature DB >> 1653276

Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.

M T Mitjavila1, J P Le Couedic, N Casadevall, S Navarro, J L Villeval, A Dubart, W Vainchenker.   

Abstract

Autonomous colony formation is a frequent event in erythroleukemia. In 13 cases of early erythroid leukemias, we investigated whether erythropoietin (Epo) autocrine stimulation was responsible for the growth factor autonomy. Epo transcripts were detected by Northern blotting in cells from one patient. These cells also expressed an Epo receptor (1,000 receptors per cell) with a 420-pM affinity and Epo was detected in the supernatant of cultured cells. In 8 of the 13 cases, Epo transcripts were revealed by the polymerase chain reaction ranging from 0.5 to 500 copies per cell. In situ hybridization proved that these Epo transcripts were present in the blast cells. No Epo gene abnormalities were detected by Southern blotting. In two cases, leukemic cells were grown in the presence of Epo-neutralizing antibodies or Epo antisense oligomers. In one case, the antibody significantly reduced autonomous growth. In contrast, the antibody had no effect in the second case in which blast cells transcribed the Epo gene at a low level. However, Epo antisense oligomers partially inhibited autonomous growth. This inhibition was reversed by addition of exogenous Epo. Overall, these results suggest that an extracellular or intracellular autocrine Epo stimulation occurs in some cases of erythroid malignancies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653276      PMCID: PMC295463          DOI: 10.1172/JCI115378

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization.

Authors:  S T Koury; M C Bondurant; M J Koury
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

2.  Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus.

Authors:  S B Krantz; E Goldwasser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

3.  Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway.

Authors:  C Laker; C Stocking; U Bergholz; N Hess; J F De Lamarter; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Polycythemia in transgenic mice expressing the human erythropoietin gene.

Authors:  G L Semenza; M D Traystman; J D Gearhart; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Erythropoietic colonies in a serum-free system: results in primary proliferative polycythaemia and thrombocythaemia.

Authors:  S Eridani; J M Dudley; B M Sawyer; T C Pearson
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

6.  Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

Authors:  J C Egrie; P M Cotes; J Lane; R E Gaines Das; R C Tam
Journal:  J Immunol Methods       Date:  1987-05-20       Impact factor: 2.303

7.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

8.  Autocrine secretion of GM-CSF in acute myeloblastic leukemia.

Authors:  D C Young; J D Griffin
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

9.  Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.

Authors:  D C Young; K Wagner; J D Griffin
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

10.  Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene.

Authors:  E Andrejauskas; C Moroni
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  11 in total

Review 1.  The physiological basis of intracrine stem cell regulation.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

2.  Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells.

Authors:  Keita Kirito; Toshihiro Nagashima; Keiya Ozawa; Norio Komatsu
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.

Authors:  T Sato; T Maekawa; S Watanabe; K Tsuji; T Nakahata
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 5.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

6.  Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

Authors:  Geza Acs; Paul J Zhang; Cindy M McGrath; Peter Acs; John McBroom; Ahmed Mohyeldin; Suzhen Liu; Huasheng Lu; Ajay Verma
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

Review 7.  Inadequate erythropoietin response to anemia: definition and clinical relevance.

Authors:  G Barosi
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

Review 8.  Erythroleukemia-historical perspectives and recent advances in diagnosis and management.

Authors:  Prajwal Boddu; Christopher B Benton; Wei Wang; Gautam Borthakur; Joseph D Khoury; Naveen Pemmaraju
Journal:  Blood Rev       Date:  2017-09-18       Impact factor: 8.250

9.  Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.

Authors:  George Mpekoulis; Efseveia Frakolaki; Styliani Taka; Anastasios Ioannidis; Alice G Vassiliou; Katerina I Kalliampakou; Kostas Patas; Ioannis Karakasiliotis; Vassilis Aidinis; Stylianos Chatzipanagiotou; Emmanouil Angelakis; Dido Vassilacopoulou; Niki Vassilaki
Journal:  PLoS One       Date:  2021-06-29       Impact factor: 3.240

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.